NEWS RELEASE
FOR IMMEDIATE RELEASE
Aspect Magnet Technologies Becomes Aspect Imaging
New Name and Identity Reflects Focus on Providing Total Imaging Solutions to the
Preclinical, Clinical and Advanced Industrial Markets
TORONTO, ON and SHOHAM, Israel -- (March 10, 2011) Aspect Magnet Technologies today announced a corporate name change in addition to the opening of its global commercial headquarters.
From its inception, the company has developed and commercialized novel permanent magnet-based MRI technologies that have been used in many research and advanced industrial installations worldwide. Effective immediately, the company becomes Aspect Imaging and will operate under its new name and identity that best describes the total solutions it provides to researchers by using its patented technologies to help provide quantitative answers to complex biological problems.
“Aspect Imaging more accurately reflects the core benefits our products and solutions provide to our customers," says Uri Rapoport, Aspect’s Founder and CEO. “In addition, our new tag line - - Powerful MRI. Simplified. - - helps to illustrate the clear value proposition that our technology provides in that we have enabled non-imaging scientists with no MRI experience to leverage the benefits of MRI, one of the most prestigious clinical imaging tools, to now help provide deeper insights and quantifiable results into their areas of research and drug development. Using the Aspect M2™ platform, MRI is now affordable, easy to use and very cost-effective to run high-throughput preclinical studies”.
As part of Aspect Imaging’s growth, the company has also announced the new opening of its Global Commercial Headquarters based in Toronto, Canada. Global sales, marketing, customer and applications support will be based in this office for Aspect’s direct sales team in North America and Europe.
About Aspect Imaging (formerly Aspect Magnet Technologies):
Aspect Imaging (www.aspectimaging.com) is the world’s leader in high-performance compact MRI imaging systems for preclinical, clinical and advanced industrial applications. In preclinical research, Aspect’s M2™ platform and suite of products enables academic researchers and pharmaceutical companies to harness the power and insights of MRI but without the cost, complexity and technical burden of traditional MRI systems. With Aspect’s integrated and simple-to-use platform, researchers can derive deep insights into their biological questions quickly, easily and cost-effectively - - and all with the push of a button. The system that has no fringe magnetic field thus the M2 can be placed anywhere in a working lab including at a scientist’s benchtop. The M2™ platform is used by leading institutions for a broad range of in vivo, ex vivo and in vitro applications including high-resolution 3D anatomical, molecular, functional and multi-modality imaging. The Aspect high-performance MRI system is used to quantify the expression of disease, to monitor disease progression and to assess therapeutic efficacy and response.
For further information, please contact:
Robert Sandler
SVP, Marketing
Aspect Imaging
T. +1 (416) 274 8166
E. rsandler@aspectimaging.com